Cargando…
Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition
BACKGROUND: Cyclooxygenase 2 (COX-2) promotes stemness in triple negative breast cancer (TNBC), highlighting COX-2 as a promising therapeutic target in these tumors. However, to date, clinical trials using COX-2 inhibitors in breast cancer only showed variable patient responses with no clear signifi...
Autores principales: | Tian, Jun, Wang, Vivian, Wang, Ni, Khadang, Baharak, Boudreault, Julien, Bakdounes, Khldoun, Ali, Suhad, Lebrun, Jean-Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885389/ https://www.ncbi.nlm.nih.gov/pubmed/33588911 http://dx.doi.org/10.1186/s13058-021-01401-2 |
Ejemplares similares
-
Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
por: Tian, Jun, et al.
Publicado: (2018) -
Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis
por: Shams, Anwar, et al.
Publicado: (2021) -
Mfge8 attenuates human gastric antrum smooth muscle contractions
por: Li, Wen, et al.
Publicado: (2021) -
MFGE8 inhibits insulin signaling through PTP1B
por: Datta, Ritwik, et al.
Publicado: (2023) -
Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance
por: Yan, Gang, et al.
Publicado: (2023)